ストックスクリーナーアプリを入手
0.86
0.12%
0.000999
前日終値:
$0.859
開ける：
$0.86
24時間の取引高:
9,605
Relative Volume:
0.01
時価総額：
$3.15M
収益：
-
当期純損益:
$-7.35M
株価収益率:
-2.2632
EPS:
-0.38
ネットキャッシュフロー:
$-5.48M
1週間 パフォーマンス:
+7.97%
1か月 パフォーマンス:
+5.65%
6か月 パフォーマンス:
+120.51%
1年 パフォーマンス:
+70.50%
1日の値動き範囲:
$0.84
$0.86
1週間の範囲:
$0.721
$0.8605
52週間の値動き範囲:
$0.2872
$3.30
Shuttle Pharmaceuticals Holdings Inc Stock (SHPH) Company Profile
名前
Shuttle Pharmaceuticals Holdings Inc
セクター
電話
(240) 403-4212
住所
401 PROFESSIONAL DRIVE, GAITHERSBURG
SHPH を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
SHPH
Shuttle Pharmaceuticals Holdings Inc
|
0.86 | 3.15M | 0 | -7.35M | -5.48M | -0.46 |
|
ZTS
Zoetis Inc
|
164.11 | 73.51B | 9.15B | 2.43B | 2.31B | 5.32 |
|
HLN
Haleon Plc Adr
|
9.535 | 43.13B | 14.26B | 1.55B | 0 | 0.3383 |
|
TAK
Takeda Pharmaceutical Co Adr
|
13.29 | 41.98B | 30.27B | 1.93B | 3.45B | 0.6044 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
22.09 | 24.97B | 16.77B | -959.00M | 1.37B | -0.85 |
|
VTRS
Viatris Inc
|
12.52 | 14.86B | 15.05B | -883.30M | 1.89B | -0.74 |
Shuttle Pharmaceuticals Holdings Inc (SHPH) 最新ニュース
Shuttle Pharmaceuticals Holdings, Inc. Engages in Sponsored Research Agreement with UCSF - Defense World
EZFill Holdings, Inc. Enters Mobile Fueling Vendor Agreement with Amazon - Defense World
Shuttle Pharma Enters into Sponsored Research Agreement - GlobeNewswire
Shuttle Pharmaceuticals Partners with UCSF for Breakthrough Prostate Cancer Diagnostic Development - StockTitan
Shuttle Pharmaceuticals stock hits 52-week low at $0.67 By Investing.com - Investing.com Canada
SHPH stock touches 52-week low at $0.75 amid market challenges - Investing.com UK
Shuttle Pharmaceuticals Submits IND Application to the U.S. FDA - GuruFocus.com
Likelihood of Approval and Phase Transition Success Rate ModelRopidoxuridine in Rectal Cancer - GlobalData
Shuttle Pharmaceuticals Initiates Phase 2 Clinical Trial for Glioblastoma Treatment- - Defense World
Shuttle Pharmaceuticals stock hits 52-week low at $0.83 By Investing.com - Investing.com Canada
Shuttle Pharma Expands Patient Enrollment for Phase 2 - GlobeNewswire
Shuttle Pharmaceuticals Starts Phase 2 Trial for Glioblastoma - TipRanks
Shuttle Pharmaceuticals Launches Phase 2 Trial for Breakthrough Glioblastoma Treatment | SHPH Stock News - StockTitan
Shuttle Pharmaceuticals Provides Third Quarter 2023 Corporate Up - GuruFocus.com
Micro Cap Company Is Soaring On Phase 2 Trial Update - MSN
500: Something went wrong - Investing.com UK
Pre-market Movers: ELAB, PHGE, CLDI, BJDX... - RTTNews
Shuttle Pharma Provides Third Quarter 2024 Corporate Update - GlobeNewswire
Shuttle Pharma Advances Phase 2 Trial, Secures $4.5M Funding for Cancer Treatment Study | SHPH Stock News - StockTitan
Shuttle Pharmaceuticals’ $4.5 Million Common Stock Offering - Global Legal Chronicle
Top 3 Penny Stocks to Watch Today – October 31, 2024 - The Global Domains News
Ironwood Pharmaceuticals (IRWD) Sees Stock Surge Amid Positive A - GuruFocus.com
Shuttle Pharma (SHPH) Stock Surges on Clinical Trial, Financing and Debt Elimination News - MSN
Shuttle Pharma Raises $4.5M for Clinical Trials - TipRanks
3 Penny Stocks to Watch Now, 10/31/24 - TipRanks
Shuttle Pharmaceuticals Successfully Doses First Patients in Phase 2 Clinical Trial for Glioblastoma Treatment - Defense World
Shuttle Pharma doses three subjects in Phase II glioblastoma treatment trial - Yahoo! Voices
"Stocks Key Trendlines: PRSO, PFIE, SHPH, BKYI, LIXT on the Verge of Breakthroughs" - Marketscreener.com
SHPHShuttle Pharmaceuticals Holdings, Inc. Latest Stock News & Market Updates - StockTitan
Canopy Growth Corporation (CGC) Stock Declines Amid Financial Re - GuruFocus.com
Shuttle Pharmaceuticals dips 6%, prices $3.5M share offering - MSN
Shuttle Pharmaceuticals Holdings, Inc. Announces Pricing of - GlobeNewswire
Shuttle Pharmaceuticals Holdings, Inc. Announces Pricing of $4.5 Million Public Offering Priced At-The-Market Under Nasdaq Rules - StockTitan
Shuttle Pharmaceuticals Holdings, Inc. Announces Pricing of $4.5 Million Public Offering Priced At-The-Market Under Nasdaq Rules - Benzinga
Shuttle Pharma Pays Off Senior Secured Convertible Note - GlobeNewswire
Micro Cap Soaring On Phase 2 Trial Update - Invezz
TSX American Preferred Stock Index (STNC) QuotePress Release - The Globe and Mail
US Stocks Mixed; McDonald's Posts Upbeat Earnings - Benzinga
Shuttle Pharmaceuticals Advances Phase 2 Glioblastoma Trial - TipRanks
Shuttle Pharma (SHPH) Stock Rises Pre-Market With Completion Site Enrollments - Stocks Telegraph
Shuttle Pharma Doses First Patients in Phase 2 Clinical - GlobeNewswire
Shuttle Pharma Doses First Patients in Phase 2 Clinical Trial of Ropidoxuridine for Treatment of Patients with Glioblastoma - Yahoo Finance
Why VF Corp Shares Are Trading Higher By Around 21%; Here Are 20 Stocks Moving Premarket - Benzinga
Shuttle Pharmaceuticals Shares Rise 63% on Drug-Study Site Update - MarketWatch
Shuttle Pharmaceuticals Advances Glioblastoma Clinical Trials - TipRanks
Shuttle Pharma Completes Clinical Trial Site Enrollment for - GlobeNewswire
Shuttle Pharma Completes Clinical Trial Site Enrollment for Phase 2 of Ropidoxuridine for Treatment of Patients with Glioblastoma - Marketscreener.com
Shuttle Pharmaceuticals to Present at ThinkEquity Conference - TipRanks
Shuttle Pharmaceuticals to Present at the 2024 ThinkEquity Conference on Wednesday, October 30, 2024 - GlobeNewswire
Shuttle Pharmaceuticals completes funding round, raises $790,000 By Investing.com - Investing.com Canada
Shuttle Pharmaceuticals completes funding round, raises $790,000 - Investing.com India
Shuttle Pharmaceuticals Holdings Inc (SHPH) 財務データ
収益
当期純利益
現金流量
EPS
1.11%
大文字化:
|
ボリューム (24 時間):